BOSTON — Will industry finally be held accountable for the harmful health effects of plastic pollution? Quite possibly, according to various speakers at a press conference...
Nearly 2 years after their final transfusion with the IGF-IR inhibitor teprotumumab (Tepezza), 82% of patients with thyroid eye disease did not need further treatment for...